ConCallIQ
Go Pro
Home › Acutaas Chemicals › Guidance

Acutaas Chemicals Management Guidance Tracker

8 forward-looking guidance items tracked across 2 quarters.

Revenue

Q3 FY26FY26 revenue growth guidance raised to ~30%Tracked

Management revised revenue growth guidance from 25% to around 30% for FY26, based on strong order book.

Q3 FY26CDMO revenue target of ₹1,000 cr by FY28Tracked

Management reiterated target of ₹1,000 cr CDMO revenue by FY28, supported by validated products and strong pipeline.

Q4 FY2625% revenue growth in FY27Active

Management guided for 25% year-on-year revenue growth in FY27, consistent with historical performance.

Q4 FY26CDMO revenue target of ₹1,000 cr by FY28Tracked

The CDMO business is expected to reach ₹1,000 cr in revenue by FY28, backed by long-term contracts and pipeline.

Margins

Q3 FY26FY26 EBITDA margin guidance raised to 32-35%Tracked

EBITDA margin guidance upgraded from 28-30% to 32-35% for full year FY26.

Q4 FY26EBITDA margin similar to FY26 levelActive

Management expects EBITDA margin to remain at similar levels as FY26 (around 35-36%), driven by product mix.

Expansion

Q3 FY26Battery chemicals commercial production by Q4 FY26Active

Electrolyte additive plant inaugurated Jan 19, 2026; trial production in Q4, commercial ramp-up from Q1 FY27.

Capex

Q4 FY26Capex of ~₹90 cr in FY27 (spillover + maintenance)Active

FY27 capex includes ~₹50 cr spillover from FY26 (electrolyte additive and pilot plant) and ~₹40 cr maintenance capex.